{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T18:49:47Z","timestamp":1780339787273,"version":"3.54.1"},"reference-count":9,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.ygyno.2011.11.010","type":"journal-article","created":{"date-parts":[[2011,12,11]],"date-time":"2011-12-11T05:25:38Z","timestamp":1323581138000},"page":"1-2","source":"Crossref","is-referenced-by-count":28,"title":["Primary surgery or neoadjuvant chemotherapy in ovarian cancer: What is the value of comparing apples with oranges?"],"prefix":"10.1016","volume":"124","author":[{"given":"Ignace","family":"Vergote","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Leunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Amant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2011.11.010_bb0005","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ygyno.2011.08.014","volume":"124","author":"Chi","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.11.010_bb0010","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","article-title":"Neoadjuvant chemotherapy or primary surgery in Stage IIIc-IV ovarian cancer","volume":"363","author":"Vergote","year":"2010","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ygyno.2011.11.010_bb0015","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1006\/gyno.1998.5213","article-title":"Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma : a retrospective analysis of 285 patients","volume":"71","author":"Vergote","year":"1998","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.11.010_bb0020","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.ygyno.2006.06.025","article-title":"Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer : a meta-analysis","volume":"103","author":"Bristow","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.11.010_bb0025","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1245\/s10434-009-0558-6","article-title":"Does neoadjuvant chemotherapy increase optimal cytoreduction rate in advanced ovarian cancer? Meta-analysis of 21 studies","volume":"16","author":"Kang","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ygyno.2011.11.010_bb0030","doi-asserted-by":"crossref","first-page":"4076","DOI":"10.1200\/JCO.2011.36.9785","article-title":"Neoadjuvant chemotherapy is the better treatment option in some patients with stage IIIc to IV ovarian cancer","volume":"29","author":"Vergote","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2011.11.010_bb0035","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1002\/(SICI)1097-0142(19981015)83:8<1555::AID-CNCR10>3.0.CO;2-R","article-title":"Patients with ovarian carcinoma upstaged to stage III after systematic lymphadenectomy have similar survival to Stage I\/II patients and superior survival to other Stage III patients","volume":"83","author":"Onda","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2011.11.010_bb0040","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1097\/IGC.0b013e31821b2568","article-title":"2010 Gynecologic Cancer InterGroup (GCIG) consensus statement on clinical trials in ovarian cancer: report from the Fourth Ovarian Cancer Consensus Conference","volume":"21","author":"Stuart","year":"2011","journal-title":"Int J Gynecol Cancer"},{"issue":"Suppl. 3","key":"10.1016\/j.ygyno.2011.11.010_bb0045","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1016\/S0959-8049(11)70152-6","article-title":"Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer","volume":"47","author":"Vergote","year":"2011","journal-title":"Eur J Cancer"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825811009267?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825811009267?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T00:24:42Z","timestamp":1543364682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825811009267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0090825811009267"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2011.11.010","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}